Position in ANAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,752,162
-$8,041,317 QoQ
Shares Held
262,995
-62.3% QoQ
Ownership
0.904%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#25
of 211 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. ANAB ranks #61 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in ANAB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,752,162 | 262,995 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $25,793,479 | 465,083 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $12,441,664 | 256,635 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,851,567 | 256,420 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,136,391 | 231,369 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,942,286 | 265,858 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,660,947 | 352,034 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,087,818 | 211,577 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,520,962 | 140,501 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,701,740 | 119,971 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,874,892 | 87,530 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,932,813 | 107,618 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,972,446 | 146,138 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,543,766 | 70,945 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $825,418 | 26,635 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $340,267 | 16,762 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,069,037 | 43,211 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,006,991 | 86,532 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,932,210 | 144,993 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $5,409,086 | 208,603 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,179,045 | 286,730 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,688,139 | 311,077 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,954,653 | 268,113 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $6,512,899 | 291,536 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,023,305 | 284,735 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||